Patents by Inventor Paul Grint

Paul Grint has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPROVEMENTS IN RESPIRATOR HOODS
    Publication number: 20240091571
    Abstract: A respirator comprising: an air supply unit arranged to deliver air at its output.
    Type: Application
    Filed: July 14, 2021
    Publication date: March 21, 2024
    Applicant: BAE SYSTEMS plc
    Inventors: Michael Fraser, Paul Douglas, Alexander Grint, Anna Welch, Alan Felstead, Neville Clokey, Julie Johnston
  • Sulfonyl-substituted bicyclic compounds as PPAR modulators for the treatment of non-alcoholic steatohepatitis
    Patent number: 9463189
    Abstract: Disclosed herein are new methods of treatment of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and other fibrotic diseases of the liver in a subject by modulating PPAR? with sulfonyl-substituted bicyclic compounds and compositions as pharmaceuticals.
    Type: Grant
    Filed: May 14, 2013
    Date of Patent: October 11, 2016
    Assignee: BPV Holdings, LLC
    Inventors: Mausumee Guha, Paul Grint
  • SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
    Publication number: 20130252970
    Abstract: Disclosed herein are new methods of treatment of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and other fibrotic diseases of the liver in a subject by modulating PPAR? with sulfonyl-substituted bicyclic compounds and compositions as pharmaceuticals.
    Type: Application
    Filed: May 14, 2013
    Publication date: September 26, 2013
    Applicant: KALYPSYS, INC.
    Inventors: Mausumee Guha, Paul Grint
  • SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
    Publication number: 20080176861
    Abstract: Disclosed herein are new methods of treatment of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and other fibrotic diseases of the liver in a subject by modulating PPAR? with sulfonyl-substituted bicyclic compounds and compositions as pharmaceuticals.
    Type: Application
    Filed: January 22, 2008
    Publication date: July 24, 2008
    Applicant: KALYPSYS, INC.
    Inventors: Mausumee Guha, Paul Grint